Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

advax

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
In the search for an effective vaccine against the human pathogen, Listeria monocytogenes (Listeria), gold glyconanoparticles… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
2014
2014
Subunit vaccines against anthrax based on recombinant protective antigen (PA) potentially offer more consistent and less… Expand
Is this relevant?
2014
2014
There is a need for additional safe and effective human vaccine adjuvants. Advax™ is a novel adjuvant produced from semi… Expand
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Although current HBV vaccines have an outstanding record of safety and efficacy, reduced immunogenicity is a problem in those of… Expand
Is this relevant?
2013
2013
West Nile virus (WNV), currently the cause of a serious U.S. epidemic, is a mosquito-borne flavivirus and member of the Japanese… Expand
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Advax™ adjuvant is derived from inulin, a natural plant-derived polysaccharide that when crystallized in the delta polymorphic… Expand
Is this relevant?
2012
2012
BACKGROUND Timely vaccine supply is critical during influenza pandemics. A recombinant hemagglutinin (rHA)-based vaccine could… Expand
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND DNA-based vaccines have been safe but weakly immunogenic in humans to date. METHODS AND FINDINGS We sought to… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2010
2010
Advax is a polysaccharide-based adjuvant that potently stimulates vaccine immunogenicity without the increased reactogenicity… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2010
2010
BACKGROUND We conducted a Phase I dose escalation trial of ADVAX, a DNA-based candidate HIV-1 vaccine expressing Clade C/B' env… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?